Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Hooper

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
The Lancet. Infectious Diseases|September 11, 2002
Fluoroquinolone resistance among Gram-positive cocciDavid C Hooper
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 1, 2002
Structure of grepafloxacin relative to activity and safety profileDavid C. Hooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologistsDavid C Hooper
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Mechanisms of fluoroquinolone resistanceDavid C. Hooper
Journal of Bacteriology|November 18, 2003
Quinolone resistance due to reduced target enzyme expressionDilek Ince, David C Hooper
The Journal of Antimicrobial Chemotherapy|December 8, 2017
Effect of Staphylococcus aureus Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess modelChunhui Chen, David C Hooper
FEMS Microbiology Letters|September 30, 2016
A simple technique for suppressor detection in Escherichia coliLaura Vinué, David C Hooper
The Journal of Bone and Joint Surgery. American Volume|February 3, 2007
Antibiotic dosing before primary hip and knee replacement as a pay-for-performance measureTimothy Bhattacharyya, David C Hooper
Antimicrobial Agents and Chemotherapy|April 28, 2005
Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacinJacob Strahilevitz, David C Hooper
BMC Microbiology|October 29, 2020
Rsp activates expression of the Cnt system in Staphylococcus aureusLaura Vinué, David C Hooper
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
The Lancet. Infectious Diseases|September 11, 2002
Fluoroquinolone resistance among Gram-positive cocciDavid C Hooper
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 1, 2002
Structure of grepafloxacin relative to activity and safety profileDavid C. Hooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologistsDavid C Hooper
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Mechanisms of fluoroquinolone resistanceDavid C. Hooper
Journal of Bacteriology|November 18, 2003
Quinolone resistance due to reduced target enzyme expressionDilek Ince, David C Hooper
The Journal of Antimicrobial Chemotherapy|December 8, 2017
Effect of Staphylococcus aureus Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess modelChunhui Chen, David C Hooper
FEMS Microbiology Letters|September 30, 2016
A simple technique for suppressor detection in Escherichia coliLaura Vinué, David C Hooper
The Journal of Bone and Joint Surgery. American Volume|February 3, 2007
Antibiotic dosing before primary hip and knee replacement as a pay-for-performance measureTimothy Bhattacharyya, David C Hooper
Antimicrobial Agents and Chemotherapy|April 28, 2005
Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacinJacob Strahilevitz, David C Hooper
BMC Microbiology|October 29, 2020
Rsp activates expression of the Cnt system in Staphylococcus aureusLaura Vinué, David C Hooper
Pageof 18